Status:

COMPLETED

Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors

Lead Sponsor:

Kowa Research Europe

Conditions:

Hypercholesterolemia

Dyslipidemia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.

Detailed Description

This is a sixteen-week, double-blind, active controlled, follow-on and 28 week single blind extension study for patients who participated in NK-104-304.

Eligibility Criteria

Inclusion

  • Completed NK-104-304 (NCT 00309738)
  • Hypercholesterolemia or combined dyslipidemia
  • 2 or more risk factors for coronary heart disease (CHD)

Exclusion

  • Withdrawn or terminated from NK-104-304 (00309738)

Key Trial Info

Start Date :

June 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2007

Estimated Enrollment :

178 Patients enrolled

Trial Details

Trial ID

NCT00344175

Start Date

June 1 2006

End Date

August 1 2007

Last Update

February 2 2010

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

Y Forskning, Bispebjerg Hospital

Copenhagen Nv, Denmark

2

Frederiks Hospital, Kardiologisk

Frederiksberg, Denmark

3

Kolesterollaboratoriet

Hellerup, Denmark

4

CCBR A/S

Vejle, Denmark